指南与共识慢性静脉疾病

欧美静脉疾病指南AGREE II比较分析

A Comparative Analysis of the European and American Venous Disease Guidelines: Bridging Evidence to Practice Using AGREE II.
指南 / 共识 · Ann Vasc Surg · 2025-05-28

BACKGROUND: Chronic venous disease guidelines are vital for standardizing care, yet their methodological quality varies among societies.…

要点

  • ESVS指南在范围与目的、利益相关者参与、编辑独立性及总体评分显著高于SVS。
  • 两指南评分者间信度均良好(ESVS ICC=0.90,SVS ICC=0.88)。
  • ESVS指南清晰度突出但实用性不足,SVS指南透明度与利益相关者参与待改进。

核心结论

  • 两指南均提供有价值指导但需改进,ESVS清晰度突出但缺乏实用性,SVS需提升透明度与利益相关者参与。

研究设计与样本

  • 来自西班牙语国家的血管外科医生使用AGREE II工具对2022年SVS与ESVS静脉疾病指南进行配对评估。

主要发现

  • ESVS在范围与目的评分显著高于SVS(95.2% vs 85.7%,P=0.017)。
  • ESVS在利益相关者参与评分显著高于SVS(85.7% vs 76.2%,P=0.036)。
  • ESVS在编辑独立性评分显著高于SVS(85.7% vs 64.3%,P=0.003)。
  • ESVS总体中位评分显著高于SVS(84.5% vs 77.0%,P=0.005)。
  • 两指南评分者间信度良好(ESVS ICC=0.90,SVS ICC=0.88)。

关键数值与推荐

  • 统计显著性设定为P<0.05。

临床怎么用

  • 临床选用静脉疾病指南时可参考AGREE II评分,ESVS在清晰度方面表现更优,SVS在透明度与利益相关者参与方面需改进。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic venous disease guidelines are vital for standardizing care, yet their methodological quality varies among societies. In Latin America, the European Society of Vascular Surgery (ESVS) and Society of Vascular Surgery (SVS) guidelines are widely used but have not been directly compared. This study uses the Appraisal of Guidelines for Research and Evaluation II (AGREE II), a validated tool, to assess and compare their quality as rated by experts, revealing strengths and limitations. METHODS: Vascular surgeons from Spanish-speaking countries evaluated the 2022 SVS and ESVS venous disease guidelines using the AGREE II instrument. Participants met predefined expertise criteria and completed paired assessments. Scores were compared using Wilcoxon signed-rank tests, with domain scores calculated as percentages and interrater reliability assessed using intraclass correlation coefficients (ICCs). Statistical significance was set at P < 0.05. RESULTS: Thirty-two vascular surgeons (47.1% response rate) participated, predominantly from Latin America (93.8%). The ESVS guideline scored significantly higher than SVS in scope and purpose (95.2% vs. 85.7%, P = 0.017), stakeholder involvement (85.7% vs. 76.2%, P = 0.036), editorial independence (85.7% vs. 64.3%, P = 0.003), and overall median score (84.5% vs. 77.0%, P = 0.005). Both guidelines showed robust interrater reliability (ESVS ICC = 0.90, SVS ICC = 0.88). CONCLUSION: Both guidelines provide valuable guidance, but improvements are needed. The ESVS guideline excels in clarity but lacks practical applicability, while the SVS guideline needs greater transparency and stakeholder involvement. Refining these aspects can enhance their impact on vascular surgery.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gómez-Gutiérrez OA, Verastegui A, Gonzalez-Urquijo M, et al. A Comparative Analysis of the European and American Venous Disease Guidelines: Bridging Evidence to Practice Using AGREE II. Ann Vasc Surg. 2025. PMID: 40447035. doi:10.1016/j.avsg.2025.05.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。